RxSight, Inc.·4

Jun 18, 4:10 PM ET

PALMISANO ROBERT J 4

Research Summary

AI-generated summary

Updated

RxSight Director Robert J. Palmisano Receives 37,037 RSU Award

What Happened
Robert J. Palmisano, an Outside Director of RxSight, Inc. (RXST), was granted 37,037 restricted stock units (RSUs) on June 17, 2026. The grant is reported as an award (transaction code A) with no purchase price listed (N/A), so there is no immediate cash transaction or reported market value in the Form 4.

Key Details

  • Transaction date: June 17, 2026 (Form 4 filed June 18, 2026) — filing appears timely.
  • Transaction type/code: Award / Grant (A).
  • Amount: 37,037 RSUs; price per share: N/A; total reported value: N/A.
  • Shares owned after transaction: not disclosed in this filing.
  • Vesting terms (footnotes): Each RSU represents a contingent right to one share. 100% of the RSUs vest on the earlier of (i) one year after the grant (June 17, 2027) or (ii) the date of the next annual meeting of stockholders, provided Palmisano continues as an Outside Director.
  • Other: Exhibit 24 (Power of Attorney) is attached to the filing.

Context
This was a compensation grant rather than a buy or sell. RSUs are a common form of director pay and only convert into shares (and potentially create a taxable event) upon vesting, subject to the stated service condition. The award itself does not indicate an immediate purchase or sale of RxSight stock.

Loading document...